Diagnostic Value of Ascitic Tumor Markers for Gastric Cancer-associated Malignant Ascites

Background/Aims: Peritoneal carcinomatosis with malignant ascites is common in patients with advanced gastric cancer (GC). The detection of tumor cells is the gold standard for the diagnosis of malignant ascites; however, it often requires complementary tests because of its low sensitivity. Herein,...

Full description

Saved in:
Bibliographic Details
Published inThe Korean Journal of Helicobacter and Upper Gastrointestinal Research Vol. 22; no. 1; pp. 38 - 49
Main Authors Yang, Yaewon, Kim, Hong Jun, Go, Se-il, Bae, Woo Kyun, Song, Eun-Kee, Byeon, Seonggyu, Kim, Hee Kyung, Jeong, Yusook, Kwon, Jihyun, Lee, Ki Hyeong, Chae, Hee Bok, Son, Seung-Myoung, Kim, Dae Hoon, Yun, Hyo Yung, Han, Hye Sook
Format Journal Article
LanguageEnglish
Published Korean College of Helicobacter and Upper Gastrointestinal Research 01.03.2022
대한상부위장관ㆍ헬리코박터학회
Subjects
Online AccessGet full text
ISSN1738-3331
2671-826X
DOI10.7704/kjhugr.2021.0058

Cover

Abstract Background/Aims: Peritoneal carcinomatosis with malignant ascites is common in patients with advanced gastric cancer (GC). The detection of tumor cells is the gold standard for the diagnosis of malignant ascites; however, it often requires complementary tests because of its low sensitivity. Herein, we measured the levels of tumor markers in the malignant ascites of GC patients (GC-ascites) and benign ascites of liver cirrhosis patients (LC-ascites) to elucidate the diagnostic value of tumor markers in GC-ascites.Materials and Methods: The levels of CEA, cancer antigen 72-4 (CA 72-4), CA 19-9, and CA 125 were measured in 138 GC-ascites and 64 LC-ascites samples obtained from the National Biobank of Korea. We performed receiver operating characteristic curve analysis to determine the optimal cutoff value for each tumor marker.Results: CEA, CA 72-4, and CA 19-9 levels were significantly higher in GC-ascites than in LC-ascites. There was no difference in tumor marker levels between GC-ascites samples irrespective of cytology. CEA, CA 72-4, and CA 19-9 had sensitivities of 85.5%, 79.0%, and 61.6%, respectively, and specificities of 96.8%, 100.0%, and 89.1%, respectively, for distinguishing GC-ascites samples from LC-ascites samples. The diagnostic accuracy was improved by combining two or more tumor markers. The combination of CEA and CA 72-4 showed the highest sensitivity (86.2%) and specificity (100%).Conclusions: Measurement of tumor markers, such as CEA, CA 72-4, and CA 19-9, in ascites samples could help diagnose GC-ascites, and combining two or more tumor markers could further increase the diagnostic yield, even in cytology-negative patients.
AbstractList Background/Aims: Peritoneal carcinomatosis with malignant ascites is common in patients with advanced gastric cancer (GC). The detection of tumor cells is the gold standard for the diagnosis of malignant ascites; however, it often requires complementary tests because of its low sensitivity. Herein, we measured the levels of tumor markers in the malignant ascites of GC patients (GC-ascites) and benign ascites of liver cirrhosis patients (LC-ascites) to elucidate the diagnostic value of tumor markers in GC-ascites.Materials and Methods: The levels of CEA, cancer antigen 72-4 (CA 72-4), CA 19-9, and CA 125 were measured in 138 GC-ascites and 64 LC-ascites samples obtained from the National Biobank of Korea. We performed receiver operating characteristic curve analysis to determine the optimal cutoff value for each tumor marker.Results: CEA, CA 72-4, and CA 19-9 levels were significantly higher in GC-ascites than in LC-ascites. There was no difference in tumor marker levels between GC-ascites samples irrespective of cytology. CEA, CA 72-4, and CA 19-9 had sensitivities of 85.5%, 79.0%, and 61.6%, respectively, and specificities of 96.8%, 100.0%, and 89.1%, respectively, for distinguishing GC-ascites samples from LC-ascites samples. The diagnostic accuracy was improved by combining two or more tumor markers. The combination of CEA and CA 72-4 showed the highest sensitivity (86.2%) and specificity (100%).Conclusions: Measurement of tumor markers, such as CEA, CA 72-4, and CA 19-9, in ascites samples could help diagnose GC-ascites, and combining two or more tumor markers could further increase the diagnostic yield, even in cytology-negative patients.
Background/Aims: Peritoneal carcinomatosis with malignant ascites is common in patients with advanced gastric cancer (GC). The detection of tumor cells is the gold standard for the diagnosis of malignant ascites; however, it often requires complementary tests because of its low sensitivity. Herein, we measured the levels of tumor markers in the malignant ascites of GC patients (GC-ascites) and benign ascites of liver cirrhosis patients (LC-ascites) to elucidate the diagnostic value of tumor markers in GC-ascites. Materials and Methods: The levels of CEA, cancer antigen 72-4 (CA 72-4), CA 19-9, and CA 125 were measured in 138 GC-ascites and 64 LC-ascites samples obtained from the National Biobank of Korea. We performed receiver operating characteristic curve analysis to determine the optimal cutoff value for each tumor marker. Results: CEA, CA 72-4, and CA 19-9 levels were significantly higher in GC-ascites than in LC-ascites. There was no difference in tumor marker levels between GC-ascites samples irrespective of cytology. CEA, CA 72-4, and CA 19-9 had sensitivities of 85.5%, 79.0%, and 61.6%, respectively, and specificities of 96.8%, 100.0%, and 89.1%, respectively, for distinguishing GC-ascites samples from LC-ascites samples. The diagnostic accuracy was improved by combining two or more tumor markers. The combination of CEA and CA 72-4 showed the highest sensitivity (86.2%) and specificity (100%). Conclusions: Measurement of tumor markers, such as CEA, CA 72-4, and CA 19-9, in ascites samples could help diagnose GC-ascites, and combining two or more tumor markers could further increase the diagnostic yield, even in cytology-negative patients. KCI Citation Count: 1
Author Byeon, Seonggyu
Kim, Hong Jun
Bae, Woo Kyun
Song, Eun-Kee
Go, Se-il
Han, Hye Sook
Yang, Yaewon
Jeong, Yusook
Yun, Hyo Yung
Chae, Hee Bok
Lee, Ki Hyeong
Kim, Dae Hoon
Son, Seung-Myoung
Kwon, Jihyun
Kim, Hee Kyung
Author_xml – sequence: 1
  givenname: Yaewon
  orcidid: 0000-0002-1773-134X
  surname: Yang
  fullname: Yang, Yaewon
– sequence: 2
  givenname: Hong Jun
  orcidid: 0000-0002-0411-668X
  surname: Kim
  fullname: Kim, Hong Jun
– sequence: 3
  givenname: Se-il
  orcidid: 0000-0002-3025-6096
  surname: Go
  fullname: Go, Se-il
– sequence: 4
  givenname: Woo Kyun
  orcidid: 0000-0003-0267-1943
  surname: Bae
  fullname: Bae, Woo Kyun
– sequence: 5
  givenname: Eun-Kee
  orcidid: 0000-0001-8836-0294
  surname: Song
  fullname: Song, Eun-Kee
– sequence: 6
  givenname: Seonggyu
  orcidid: 0000-0002-4989-002X
  surname: Byeon
  fullname: Byeon, Seonggyu
– sequence: 7
  givenname: Hee Kyung
  orcidid: 0000-0001-7416-4727
  surname: Kim
  fullname: Kim, Hee Kyung
– sequence: 8
  givenname: Yusook
  orcidid: 0000-0002-3614-8045
  surname: Jeong
  fullname: Jeong, Yusook
– sequence: 9
  givenname: Jihyun
  orcidid: 0000-0001-8128-3310
  surname: Kwon
  fullname: Kwon, Jihyun
– sequence: 10
  givenname: Ki Hyeong
  orcidid: 0000-0002-7830-5950
  surname: Lee
  fullname: Lee, Ki Hyeong
– sequence: 11
  givenname: Hee Bok
  orcidid: 0000-0002-9711-6434
  surname: Chae
  fullname: Chae, Hee Bok
– sequence: 12
  givenname: Seung-Myoung
  orcidid: 0000-0002-1646-4649
  surname: Son
  fullname: Son, Seung-Myoung
– sequence: 13
  givenname: Dae Hoon
  orcidid: 0000-0001-9873-4907
  surname: Kim
  fullname: Kim, Dae Hoon
– sequence: 14
  givenname: Hyo Yung
  orcidid: 0000-0002-5592-1371
  surname: Yun
  fullname: Yun, Hyo Yung
– sequence: 15
  givenname: Hye Sook
  orcidid: 0000-0001-6729-8700
  surname: Han
  fullname: Han, Hye Sook
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002819145$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kcuLE0EQxhtZwbju3eNcPUzs9-MYoq6BlQUJoqem0o-xk9lp6Z4c9r-3kxEPgn2ppur7fVD1vUY3U54CQm8JXiuF-fvT8ed5KGuKKVljLPQLtKJSkV5T-f0GrYhiumeMkVfortYjbk9iQrVaoR8fEgxTrnNy3TcYz6HLsdtUly6N_fkpl-4LlFMotYvtfw91Lm2yhcmF0kOt2SWYg2-qMQ0TTPNCh_oGvYww1nD3p96i_aeP--3n_uHxfrfdPPSOMqx7biiRGMBjRj3lLkqmIsE-YgkHJowR3LWNvJBGHAQQGjyjLhKuiWdSsVv0brGdSrQnl2yGdK1DtqdiN1_3O2sM01zSpt0tWp_haH-V9ATl-QpcG7kMFkpbfAyWywOPCgcjZODguNZMCM-ZMsaAkq554cXLlVxrCfGvH8H2EopdQrGXUOwllIbIf5B2KJhTnuYCafw_-Bt5C5NS
CitedBy_id crossref_primary_10_1007_s12029_023_00984_7
crossref_primary_10_1002_hsr2_1107
crossref_primary_10_7704_kjhugr_2022_0071
Cites_doi 10.1590/S0004-28032007000300011
10.1016/S1665-2681(19)30865-8
10.1002/ijc.28373
10.1159/000080281
10.3322/caac.21660
10.1007/s00432-009-0684-3
10.5230/jgc.2019.19.e27
10.1002/1097-0142(19870115)59:2<213::AID-CNCR2820590206>3.0.CO;2-I
10.1007/s10120-011-0091-8
10.1016/j.canlet.2004.09.031
10.3748/wjg.v11.i46.7374
10.5114/aoms.2016.64044
10.1590/S0004-28032008000300010
10.1016/j.ejim.2006.12.001
10.15386/cjmed-409
10.1006/gyno.2001.6575
10.1038/sj.bjc.6602802
10.7314/APJCP.2015.16.2.719
10.18632/oncotarget.10391
10.1016/j.amjsurg.2006.05.007
10.1590/S0004-28032002000100004
10.1007/s11845-013-1051-6
10.1111/j.1572-0241.1999.01152.x
10.1007/s00432-014-1601-y
10.1016/j.clinbiochem.2013.02.010
10.1002/jso.23472
10.5754/hge11209
10.1007/s00432-006-0189-2
10.1007/s00268-013-2385-y
ContentType Journal Article
DBID AAYXX
CITATION
DOA
ACYCR
DOI 10.7704/kjhugr.2021.0058
DatabaseName CrossRef
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
DatabaseTitleList CrossRef


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2671-826X
EndPage 49
ExternalDocumentID oai_kci_go_kr_ARTI_9938462
oai_doaj_org_article_46b4f70e956e4ac488355d437999a76c
10_7704_kjhugr_2021_0058
GroupedDBID 5-W
8JR
8XY
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BCNDV
CITATION
EF.
GROUPED_DOAJ
OK1
M~E
ACYCR
ID FETCH-LOGICAL-c2308-492160aad032d24cf637f10df06ab359954c058d5695b5a12ed32cf1481d3673
IEDL.DBID DOA
ISSN 1738-3331
IngestDate Tue Nov 21 21:43:03 EST 2023
Wed Aug 27 01:22:02 EDT 2025
Thu Apr 24 23:04:37 EDT 2025
Tue Jul 01 02:38:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2308-492160aad032d24cf637f10df06ab359954c058d5695b5a12ed32cf1481d3673
ORCID 0000-0002-1773-134X
0000-0001-9873-4907
0000-0002-5592-1371
0000-0001-8836-0294
0000-0002-3025-6096
0000-0002-3614-8045
0000-0002-9711-6434
0000-0001-6729-8700
0000-0001-8128-3310
0000-0002-0411-668X
0000-0003-0267-1943
0000-0002-7830-5950
0000-0002-1646-4649
0000-0002-4989-002X
0000-0001-7416-4727
OpenAccessLink https://doaj.org/article/46b4f70e956e4ac488355d437999a76c
PageCount 12
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9938462
doaj_primary_oai_doaj_org_article_46b4f70e956e4ac488355d437999a76c
crossref_primary_10_7704_kjhugr_2021_0058
crossref_citationtrail_10_7704_kjhugr_2021_0058
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03
PublicationDecade 2020
PublicationTitle The Korean Journal of Helicobacter and Upper Gastrointestinal Research
PublicationYear 2022
Publisher Korean College of Helicobacter and Upper Gastrointestinal Research
대한상부위장관ㆍ헬리코박터학회
Publisher_xml – name: Korean College of Helicobacter and Upper Gastrointestinal Research
– name: 대한상부위장관ㆍ헬리코박터학회
References ref13
ref12
ref15
ref14
ref30
ref11
ref10
Ahadi (ref7) 2014
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref24
  doi: 10.1590/S0004-28032007000300011
– ident: ref9
  doi: 10.1016/S1665-2681(19)30865-8
– ident: ref2
  doi: 10.1002/ijc.28373
– ident: ref21
  doi: 10.1159/000080281
– ident: ref1
  doi: 10.3322/caac.21660
– ident: ref13
  doi: 10.1007/s00432-009-0684-3
– ident: ref17
  doi: 10.5230/jgc.2019.19.e27
– ident: ref18
  doi: 10.1002/1097-0142(19870115)59:2<213::AID-CNCR2820590206>3.0.CO;2-I
– ident: ref5
  doi: 10.1007/s10120-011-0091-8
– ident: ref27
  doi: 10.1016/j.canlet.2004.09.031
– ident: ref23
  doi: 10.3748/wjg.v11.i46.7374
– ident: ref25
  doi: 10.5114/aoms.2016.64044
– ident: ref12
  doi: 10.1590/S0004-28032008000300010
– ident: ref3
  doi: 10.1016/j.ejim.2006.12.001
– ident: ref4
  doi: 10.15386/cjmed-409
– ident: ref19
  doi: 10.1006/gyno.2001.6575
– ident: ref26
  doi: 10.1038/sj.bjc.6602802
– start-page: 418
  volume-title: Diagnostic value of carcinoembryonic antigen in malignancy-related ascites: systematic review and meta-analysis
  year: 2014
  ident: ref7
– ident: ref10
  doi: 10.7314/APJCP.2015.16.2.719
– ident: ref6
  doi: 10.18632/oncotarget.10391
– ident: ref11
  doi: 10.1016/j.amjsurg.2006.05.007
– ident: ref14
  doi: 10.1590/S0004-28032002000100004
– ident: ref16
  doi: 10.1007/s11845-013-1051-6
– ident: ref20
  doi: 10.1111/j.1572-0241.1999.01152.x
– ident: ref22
  doi: 10.1007/s00432-014-1601-y
– ident: ref8
  doi: 10.1016/j.clinbiochem.2013.02.010
– ident: ref29
  doi: 10.1002/jso.23472
– ident: ref30
  doi: 10.5754/hge11209
– ident: ref15
  doi: 10.1007/s00432-006-0189-2
– ident: ref28
  doi: 10.1007/s00268-013-2385-y
SSID ssj0000601287
ssib044750973
Score 2.1753354
Snippet Background/Aims: Peritoneal carcinomatosis with malignant ascites is common in patients with advanced gastric cancer (GC). The detection of tumor cells is the...
Background/Aims Peritoneal carcinomatosis with malignant ascites is common in patients with advanced gastric cancer (GC). The detection of tumor cells is the...
SourceID nrf
doaj
crossref
SourceType Open Website
Enrichment Source
Index Database
StartPage 38
SubjectTerms ascites
biomakers, tumor
diagnosis
stomach neoplasms
내과학
Title Diagnostic Value of Ascitic Tumor Markers for Gastric Cancer-associated Malignant Ascites
URI https://doaj.org/article/46b4f70e956e4ac488355d437999a76c
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002819145
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Korean Journal of Helicobacter Upper Gastrointestinal Research , 2022, 22(1), , pp.38-49
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELYQEwsCAaK8ZCEWhlC_4iRjeRYkmAoqk-XYTiktLQrtym_nLglVWWBhSSTrrCTfObnvlPN3hJwolrOghItsLpMII0SUpU5E3BWQMltuedVj6f5Bdx_VXT_uL7X6wpqwWh64Bq6tdK6KhAXg8UFZB-sNIqRHFb0ss4l2-PVlGVtKpmAloYod6tBUuyHhjZZS8vofZZIw1R69vswHKAYq-Bn21fsRkyrpfog0k7JYijTXG2S9oYi0U9_aJlkJky3yfFnXxMEYfbLjeaDTgnYgfuFAb_42LSluuwEyR4GG0huL_TgcvUCnlpFtnBA8WI2HA6x-qWeHj23Su77qXXSjpi1C5CBfSCOVCa6ZtZ5J4YVyhZZJwZkvmAbAUUBMOXgoH-sszmPLRfBSAPQKqKnUidwhq5PpJOwSGuvcQ8zOpfcFpCGp5SGVVjGnVcKsky3S_sbFuEYyHDtXjA2kDoikqZE0iKRBJFvkdDHjvZbL-MX2HKFe2KHQdTUA7jeN-81f7m-RY3CUGblhNR_Pg6kZlQbSgVsD5Av4ldj7jyvtkzWBWx-q-rMDsjor5-EQCMksP6rWHhzvP6--AP9p2tE
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+Value+of+Ascitic+Tumor+Markers+for+Gastric+Cancer-associated+Malignant+Ascites&rft.jtitle=The+Korean+journal+of+helicobacter+and+upper+gastrointestinal+research&rft.au=Yang+Yaewon&rft.au=Kim+Hong+Jun&rft.au=Go+Se-il&rft.au=%EB%B0%B0%EC%9A%B0%EA%B7%A0&rft.date=2022-03-01&rft.pub=%EB%8C%80%ED%95%9C%EC%83%81%EB%B6%80%EC%9C%84%EC%9E%A5%EA%B4%80%E3%86%8D%ED%97%AC%EB%A6%AC%EC%BD%94%EB%B0%95%ED%84%B0%ED%95%99%ED%9A%8C&rft.issn=1738-3331&rft.eissn=2671-826X&rft.spage=38&rft.epage=49&rft_id=info:doi/10.7704%2Fkjhugr.2021.0058&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_9938462
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-3331&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-3331&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-3331&client=summon